Phase 1 summary of plasma concentration–QTc analysis for idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors and AML

出版年份 2018 全文链接

标题

作者

关键词

Idasanutlin, MDM2 antagonist, QT interval, Concentration–QTcF

出版物

Volume 81, Issue 3, Pages 597-607

出版商

Springer Nature

发表日期

2018-02-01

DOI

10.1007/s00280-018-3534-7

参考文献

查看 5 条相关文献

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation